Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,156 | 42 | 95.3% |
| Education | $56.99 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $210.41 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $179.99 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $109.37 | 1 | $0 (2018) |
| Biofrontera Inc. | $105.32 | 5 | $0 (2024) |
| AbbVie Inc. | $104.62 | 5 | $0 (2021) |
| PFIZER INC. | $90.92 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $79.85 | 2 | $0 (2019) |
| Arcutis Biotherapeutics, Inc. | $72.14 | 3 | $0 (2024) |
| Galderma Laboratories, L.P. | $62.74 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $56.01 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.45 | 6 | Regeneron Healthcare Solutions, Inc. ($52.82) |
| 2023 | $342.90 | 9 | GENZYME CORPORATION ($141.04) |
| 2022 | $113.56 | 5 | GENZYME CORPORATION ($45.87) |
| 2021 | $62.60 | 3 | AbbVie Inc. ($28.13) |
| 2020 | $40.42 | 2 | AbbVie Inc. ($20.92) |
| 2019 | $131.53 | 5 | Sun Pharmaceutical Industries Inc. ($79.85) |
| 2018 | $338.14 | 10 | Novartis Pharmaceuticals Corporation ($109.37) |
| 2017 | $42.16 | 3 | MERZ NORTH AMERICA, INC. ($14.37) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/08/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Dermatology | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $25.69 | General |
| Category: DERMATOLOGY | ||||||
| 01/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $115.85 | General |
| Category: Immunology | ||||||
| 09/12/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $29.75 | General |
| 07/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 03/29/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 02/14/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Immunology | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Immunology | ||||||
| 10/11/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/20/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: DERMATOLOGY | ||||||
| 02/23/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
| 11/09/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 09/02/2021 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: DERMATOLOGY | ||||||
| 06/06/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 10/19/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 435 | 877 | $125,602 | $22,894 |
| 2022 | 11 | 555 | 4,255 | $210,878 | $37,128 |
| 2021 | 10 | 380 | 688 | $100,317 | $20,947 |
| 2020 | 7 | 255 | 462 | $55,095 | $14,547 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 56 | 68 | $23,422 | $4,577 | 19.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 109 | 125 | $28,659 | $4,082 | 14.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 70 | $18,897 | $3,524 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 36 | $13,754 | $3,384 | 24.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 88 | 485 | $14,602 | $2,390 | 16.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 15 | $7,673 | $1,920 | 25.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 26 | 26 | $8,000 | $1,396 | 17.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 39 | $6,598 | $992.09 | 15.0% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 13 | $3,996 | $629.46 | 15.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 61 | 70 | $24,224 | $5,504 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 93 | $25,404 | $5,186 | 20.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 119 | 142 | $33,584 | $4,429 | 13.2% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 14 | 3,200 | $38,400 | $3,975 | 10.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 28 | 32 | $16,292 | $3,746 | 23.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2022 | 13 | 15 | $13,243 | $3,072 | 23.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 99 | 547 | $16,454 | $2,756 | 16.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 39 | 42 | $13,092 | $2,620 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 34 | $13,169 | $2,283 | 17.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 52 | 57 | $9,736 | $2,166 | 22.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 21 | 23 | $7,280 | $1,390 | 19.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 44 | 49 | $13,771 | $4,082 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 68 | $15,689 | $3,666 | 23.4% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 21 | 21 | $10,706 | $2,768 | 25.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 80 | 89 | $20,389 | $2,471 | 12.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 33 | $9,401 | $2,145 | 22.8% |
About Dr. Brittany Baker, MD
Dr. Brittany Baker, MD is a Dermatology healthcare provider based in Jackson, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265653745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brittany Baker, MD has received a total of $1,213 in payments from pharmaceutical and medical device companies, with $141.45 received in 2024. These payments were reported across 43 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,156).
As a Medicare-enrolled provider, Baker has provided services to 1,625 Medicare beneficiaries, totaling 6,282 services with total Medicare billing of $95,515. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Jackson, WY
- Active Since 05/01/2007
- Last Updated 08/04/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1265653745
Products in Payments
- DUPIXENT (Biological) $331.45
- COSENTYX (Biological) $109.37
- EUCRISA (Drug) $90.92
- AMELUZ (Drug) $86.33
- LIBTAYO (Biological) $58.95
- SPEVIGO (Drug) $56.01
- Sotyktu (Drug) $33.27
- Humira (Biological) $31.02
- BOTOX COSMETIC (Biological) $29.05
- SKYRIZI (Biological) $28.13
- Skyrizi (Biological) $24.55
- ABSORICA (Drug) $22.86
- HUMIRA (Biological) $20.92
- Zoryve (Drug) $19.60
- Ameluz (Drug) $18.99
- TALTZ (Drug) $18.37
- Levulan (Drug) $14.12
- SOOLANTRA (Drug) $13.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jackson
Dr. Robert Brodell, M.d, M.D
Dermatology — Payments: $46,944
Dr. William Teer, M.d, M.D
Dermatology — Payments: $19,103
Carlton Daniel, Md, MD
Dermatology — Payments: $9,542
Dr. Ashton Davis, Md, MD
Dermatology — Payments: $8,368
Dr. Robert Jones, M.d, M.D
Dermatology — Payments: $8,123
Dr. Colleen Powers, Md, MD
Dermatology — Payments: $7,101